Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors : from guidelines to clinical practice in solid tumors
Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide
Differential molecular mechanism of docetaxel–octreotide combined treatment according to the docetaxel-resistance status in PC3 prostate cancer cells
Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes
Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis
Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124],
α-Cyano-4-hydroxycinnamate induces apoptosis in Dalton’s lymphoma cells : role of altered cell survival-regulatory mechanisms
A functionalized poly(amidoamine) nanocarrier-loading 5-fluorouracil : pH-responsive drug release and enhanced anticancer effect
XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts
Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia
Add-on-therapy with bevacizumab in children and adolescents with poor prognosis non-CNS solid tumors
Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment
Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients